• Google’s Page Describes Speech Malady, Funds Research
  • J&J Wins Expanded Approval of Simponi for Bowel Disease
  • Bristol-Myers Targets Heart-Failure Drugs in R&D Effort
  • Merck Plans $6.5 Billion Bond Offering for Stock Repurchases
  • Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
  • Actavis Gaining More From Purchase Than Sale: Real M&A
  • Fraud Settlement at Ranbaxy Set to Spur Exports: Corporate India
  • Nintendo, Apple, Samsung, Metso: Intellectual Property
  • Roche Wins FDA Approval for Test to Target Lung Cancer
  • Swiss Stocks Rise, Extending Five-Year High; Adecco Gains
  • Warren’s Bank Trials, Visa Probe, Ratings: Compliance
  • Primecap Rides Health to Top Growth Fund: Riskless Return
  • Jolie Mastectomy Fuels Debate on Breast Cancer Treatment
  • Bonanza Creek’s 19% Surge Canceled as Other Swings Stands
  • Vaginal Bulge Surgery Fails in One in Four Women in Study
« Previous 1 2 3 4 5 Next »